Carbohydrates: Structure, Absorption, and Metabolic Regulation

RBCs, mitochondria, and the central role of glucose

• RBCs are the only macronutrient-using cells that depend on carbohydrate to the extreme: they rely on glucose because they lack mitochondria.
• Without mitochondria, RBCs cannot perform the citric acid cycle, so they cannot oxidize fatty acids, proteins, or ketones. They rely exclusively on glycolysis of glucose for ATP.
• This is part of the body’s defense of Euglycemia: the circulating glucose level is maintained at about $4\ ext{g} \; \text{or} \; 5\ \text{mmol}$ to meet the needs of RBCs and brain.
• The body can recycle substrates from other tissues to support blood glucose when needed.
• Between meals or during prolonged fasting, interorgan exchange (muscle, liver, adipose) supports brain and RBCs and helps defend blood glucose levels.

Interorgan nutrient exchange and hormonal control

• Major tissues that support brain and RBC glucose during fasting or between meals: muscle (largest glucose store), liver, and adipose tissue.
• Hormonal profiles in the blood adapt the interorgan exchange to defend blood glucose levels.
• In fed vs fasted vs starved states, the hormone milieu (notably insulin) changes reactions and substrate utilization.

Carbohydrates: digestion, absorption, and transport

• We'll cover digestion quickly, then focus on absorption and how hormones (e.g., insulin) shape the response.
• Transporters for glucose uptake differ by tissue:
  • Insulin-sensitive tissues: muscle and adipose tissue express GLUT-4; these tissues respond to insulin to take up glucose.
  • Brain and RBCs do not rely on GLUT-4 for glucose uptake under typical conditions; they are prioritized for glucose uptake.
• Insulin resistance impairs glucose uptake in muscle and adipose tissue via GLUT-4 dysfunction.
• The liver does not require GLUT-4; it can take up glucose even when insulin signaling is impaired, but insulin resistance in the liver can alter enzyme activities and contribute to NAFLD/NASH.

Two key glucose transporters and their roles

• SGLT1 (Sodium-Dependent Glucose Transporter 1): apical transporter on enterocytes; actively transports glucose and galactose into enterocytes along with Na+ (Na+-coupled).
• Na+/K+-ATPase on the basolateral side: expels Na+ and brings K+ into enterocytes to power the Na+ gradient, enabling SGLT1 function.
• GLUT2: basolateral transporter in enterocytes; also facilitates apical uptake in some contexts; takes up glucose, galactose, and fructose after entry into enterocytes.
• GLUT5: apical transporter for fructose uptake into enterocytes; fructose then exits via GLUT2 on the basolateral side to the portal blood.
• Fructose vs glucose/galactose uptake: fructose uses GLUT5 on the apical side, less competition, and GLUT2 on the basolateral side for exit. GLUT2 does not require insulin for transport.
• Fructose metabolism: fructose is quickly taken up by the liver and can feed into glycolysis, gluconeogenesis, and lipogenesis; much of hepatic lipogenesis occurs with fructose due to rapid uptake and metabolism.

What happens in the liver with monosaccharides

• Glucose in the portal vein is taken up by hepatocytes via GLUT2 and may be used for energy, converted to nonessential amino acids, or stored as glycogen; excess is converted to triglycerides and packaged into VLDL.
• Galactose is converted to glucose in the liver (a relatively energy-intensive step).
• Fructose is taken up by liver cells and eventually converted to glucose or entered into glycolysis at different points; its metabolism can be lipogenic (favoring fat synthesis).
• The liver has a decision tree for monosaccharides: meet cellular energy needs, support growth/division by feeding the citric acid cycle and amino acid synthesis, or store as glycogen and lipids.
• High glycemic load foods trigger large insulin responses, which can drive de novo lipogenesis and influence lipid profiles over time.

Carbohydrate types: categories and examples

• Simple vs complex carbohydrates:
  • Simple monosaccharides: absorbable forms — $\text{glucose}, \; \text{fructose}, \; \text{galactose}$.
  • Disaccharides (simple carbohydrates): in this lecture, examples include maltose (glucose-glucose, alpha-1,4), lactose (galactose-glucose, beta-1,4), and fructose (context suggests sucrose, glucose-fructose; enzymes include maltase, sucrase, lactase).
  • Complex carbohydrates: oligosaccharides (roughly 3–20 sugars; raffinose is a 3-sugar oligosaccharide found in beans and cruciferous vegetables; digestion can produce gas due to incomplete digestion), and polysaccharides (amylose, amylopectin in plants; glycogen in animals).
• Raffinose example: in beans and cruciferous vegetables; partially digested; gas production due to microbial fermentation in the large intestine.
• Polysaccharides storage and structure:
  • Plants store starch as amylose and amylopectin; animal storage uses glycogen (liver and skeletal muscle).
  • Amylose: linear polymer forming relatively simple, sometimes sweeter-tasting components; amylopectin: branched, more complex, higher glycemic episode potential.
  • Glycogen: highly branched with 1→4 and 1→6 linkages; more branching allows rapid glucose release when energy is needed.
  • Fiber (cellulose in plants) is a beta-linked polysaccharide (beta-1,4); humans cannot digest it; ruminants and some gut microbes can.
• Fibers in foods:
  • Soluble fibers: fermentable by gut bacteria; examples include fructans, beta-glucans (oats, barley), pectins (citrus, fruits), gums; they form viscous gels and slow gastric emptying, blunt the glycemic response, and bind bile and fatty acids.
  • Insoluble fibers: cellulose, lignin, hemicellulose; provide bulk, speed intestinal transit, and contribute to stool bulk.
  • Fibers can be fermentable or nonfermentable; fermentable fibers produce short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate, and promote healthy gut microbiota; nonfermentable fibers mainly add bulk.
  • Viscous gel-forming fibers (soluble): most effective at slowing absorption, reducing postprandial glucose and lipid absorption, and contributing to fullness; work synergistically with insoluble fibers in whole foods.
• Dietary sources of fiber and their components:
  • Cellulose, hemicellulose: bran, whole grains, nuts (e.g., almonds) – structural plant components.
  • Pectins: citrus fruits, plums, kiwi; present in fruit pulp.
  • Beta-glucans: oats and barley; highly associated with cholesterol-lowering effects.
  • Fructans: found in many fruits and vegetables; supportive of microbiota; psyllium is a soluble fiber supplement.
• Practical note on fiber in foods:
  • Whole foods provide a mix of soluble and insoluble fiber; supplements (e.g., psyllium) may increase bulk but are less effective when not consumed with meals.
  • The combination of soluble and insoluble fibers creates a gel matrix that slows absorption and improves glycemic control; alone, high soluble fiber may not yield the same benefits as when paired with insoluble fiber.

Fractional carbohydrates and metabolism: pentoses, hexoses, and beyond

• Hexose sugars (6 carbons): glucose, galactose, fructose (most important in human metabolism).
• Pentose sugars (5 carbons): ribose (RNA/DNA backbone), xylose; ribose is part of nucleotide synthesis; ribulose participates in the pentose phosphate pathway (PPP).
• Other 5-carbon sugars (e.g., ribose, xylose) are present in the diet; PPP-derived sugars support nucleotide synthesis rather than immediate energy production.
• The pentose phosphate pathway (PPP): converts glucose-6-phosphate into ribose-5-phosphate for nucleotide synthesis; also generates NADPH for biosynthetic reactions and antioxidant defense.
• Glycoconjugates and glycosylation:
  • Glycoproteins and glycolipids: sugars attached to proteins or lipids; important for cell membrane structure (glycocalyx) and protein/enzyme function.
  • Hemoglobin A1c as a marker of chronic blood glucose levels reflects non-enzymatic glycation of hemoglobin, not regular glycosylation.
• Nucleotides, nucleic acids, and energy currency:
  • Ribose-based sugars are fundamental to DNA/RNA backbone and ATP formation; glucose supports nucleotide synthesis via PPP and glycolytic intermediates.
• Fructose and lipogenesis (lipid biosynthesis):
  • Fructose is lipogenic in the liver more efficiently than glucose due to its bypassing of phosphofructokinase regulation and rapid hepatic uptake; contributes to de novo lipogenesis.
  • Evolutionary perspective: animals seek fruit for fructose to support fat accumulation; enzyme SNIPs allow greater lipogenic potential of fructose, enhancing energy storage.

Glycogen, starch, and storage forms

• Plant starch: amylose (linear) and amylopectin (branched); amylose is digested more slowly than amylopectin; branching increases enzymatic access and rapid glucose release.
• Animal storage: glycogen (highly branched) stores glucose in liver and muscle; liver glycogen is particularly important for maintaining blood glucose during fasting.
• Glycogen structure and functional implications:
  • One-four linkages predominate in glycogen chains; additional one-six linkages create branches for rapid mobilization of glucose units.
• Dietary processing and food structure: whole kernel anatomy (bran, germ, endosperm) affects fiber content and metabolic impact; removing bran reduces insoluble fiber and nutrient density.

Absorption: luminal digestion, brush-border processing, and enterocyte uptake

• Luminal digestion vs membrane (brush-border) digestion:
  • Luminal: mouth and small intestine lumen where carbohydrates are initially broken down by amylases into dextrins and simple sugars.
  • Brush border: enterocyte surface enzymes (maltase, sucrase, lactase, isomaltase, dextrinase) break down disaccharides and dextrins to monosaccharides for absorption.
• Stages of carbohydrate digestion:
  • Mouth: salivary amylase begins breaking alpha-1,4 glycosidic bonds in starch (amylose/amylopectin).
  • Stomach: minimal digestion for carbohydrates; enzymes are denatured by acid.
  • Small intestine: pancreatic amylase continues luminal digestion of starch; dextrins produced; brush-border enzymes finalize disaccharide digestion to monosaccharides.
• Absorbed monosaccharides:
  • Glucose and galactose: absorbed via SGLT1 (apical Na+-dependent transporter) into enterocytes; sodium gradient maintained by Na+/K+-ATPase on basolateral side.
  • Glucose and galactose exit enterocytes via GLUT2 on the basolateral membrane into portal blood.
  • Fructose: absorbed primarily via GLUT5 on the apical side; exits enterocytes via GLUT2 on the basolateral side into portal blood.
• Energetics and osmolarity considerations:
  • SGLT1 brings glucose/galactose against their concentration gradient using the Na+ gradient; Na+/K+-ATPase extrudes Na+ to sustain gradient.
  • GLUT2 provides facilitated diffusion down its concentration gradient; GLUT2 also mediates efflux of glucose, galactose, and fructose into portal blood.
  • When luminal glucose is high, GLUT2 can be recruited to the apical membrane to enhance uptake; after equilibration, SGLT1 continues transporting glucose against gradient.
• Post-absorption: monosaccharides reach the liver via the portal vein; the liver can uptake glucose, galactose, and fructose for metabolism or storage as glycogen or lipids.

Metabolic fates of monosaccharides in the liver

• Glucose in hepatocytes:
  • Immediate energy demand: can be burned in glycolysis to ATP.
  • If energy needs are met: glucose can contribute to nonessential amino acid synthesis via the citric acid cycle and anaplerotic reactions.
  • Excess glucose: can be converted to triglycerides and exported as VLDL; de novo lipogenesis may occur when glycogen stores are full.
• Galactose:
  • Converted to glucose in the liver (energy-intensive step) and then follows the glucose fate.
• Fructose:
  • Uptaken by liver; converted to glucose or enter glycolysis at different points; ultimately fuels ATP production or lipogenesis; can be lipogenic depending on flux and regulation.
• Glycogen storage vs lipogenesis:
  • If energy needs are satisfied and glycogen stores are topped up, excess glucose can be diverted to fatty acid synthesis and stored as triglycerides.
• Glycemic response and insulin:
  • High glycemic foods trigger rapid glucose spikes and large insulin responses, potentially leading to an overshoot below baseline (reactive hypoglycemia) and beta-cell stress with chronic high GI/GL diets.

Glycemic response, insulin resistance, and health implications

• High glycemic load and insulin response:
  • Mealtime with low fiber and high glycemic index leads to rapid glucose rise and large insulin release, followed by a rapid fall (potential fatigue, brain energy impact).
  • Repeated spikes may contribute to impaired beta-cell function and insulin resistance over decades.
• Insulin resistance concepts:
  • Insulin resistance is characterized by a reduced ability of insulin to promote glucose uptake in target tissues, particularly muscle and adipose tissue, via impaired signaling downstream of the insulin receptor.
  • The precise mechanisms are multifactorial and not fully understood; several pathways contribute (e.g., serine phosphorylation of IRS-1, inflammatory signaling, lipid intermediates).
• Consequences and broader context:
  • Insulin resistance in the liver can alter enzyme activities and contribute to NAFLD/NASH.
  • Excess carbohydrate intake, especially with high GI, can drive de novo lipogenesis in the liver and contribute to dyslipidemia and obesity risk if energy balance is not achieved.
  • In the long term, sustained high glycemic episodes stress pancreatic beta cells, accelerating beta-cell failure in type 2 diabetes.
• Evolutionary and practical perspectives:
  • Fructose’s lipogenic potential may have played a role in fruit-seeking behavior and energy storage strategies in some species.
  • In modern diets, high-fructose intake together with refined carbohydrates can exacerbate lipogenesis and metabolic syndrome risk.

Practical dietary implications: fiber, timing, and meals

• Dietary fiber and metabolic health:
  • Soluble, viscous fibers (fructans, beta-glucans, pectins, gums) slow gastric emptying, blunt postprandial glucose excursions, and lower serum cholesterol and triglycerides by binding bile acids and fatty acids for excretion.
  • Insoluble fibers (cellulose, lignin, hemicellulose) increase stool bulk and speed intestinal transit, aiding regularity and reducing intraluminal pressure.
  • Soluble fibers promote fermentation by gut microbiota, producing SCFAs (butyrate, propionate, acetate) that provide colonocyte energy (butyrate) and influence systemic metabolism.
• Mechanistic effects of fiber in meals:
  • Gel formation from soluble fibers slows carbohydrate digestion and absorption, reducing peak glucose and insulin responses.
  • Insoluble fibers act synergistically with soluble fibers to form a scaffold that enhances the moderating effects on absorption.
  • When fiber is consumed with meals, the glycemic response is blunted; when consumed as an isolated supplement, benefits may be reduced.
• Ketogenic and pharmacologic considerations:
  • Some GLP-1 receptor agonists (e.g., Ozempic, Wegovy) slow gastric emptying and promote fullness, a property that fiber can mimic in a dietary context by front-loading fiber before or during meals.
• Balancing energy and nutrition:
  • Excess soluble fiber can bind minerals (calcium, magnesium, sodium, potassium) and bile acids; excessive intake can impact electrolyte balance and absorption.
  • In most individuals, increasing fiber through whole foods improves metabolic outcomes and reduces cardiovascular risk, type 2 diabetes risk, and obesity risk.
• Practical cautions:
  • Too much fiber acutely can cause GI discomfort or a risk of obstruction in rare cases; gradual increase and adequate hydration are recommended.
  • Whole foods provide a mixture of soluble and insoluble fiber that works synergistically; isolating fibers (e.g., fiber supplements) without accompanying nutrients may not yield the same benefits.
• Real-world takeaways:
  • Prioritize complex carbohydrates with fiber, especially when paired with protein and healthy fats to slow absorption further.
  • Favor whole grains, legumes, fruits, vegetables, nuts, and seeds over highly processed carbohydrate-rich foods to optimize glycemic control and lipid profiles.
  • Consider the timing and composition of meals to moderate postprandial glucose and insulin responses.

Summary: integrated view of carbohydrates in metabolism

• Carbohydrates are essential for brain and RBCs, but not solely for energy in most tissues; rather, they act as regulators of metabolism and signals for growth, replication, and energy storage.
• The body maintains euglycemia through interorgan cooperation (muscle, liver, adipose) and a network of transporters that regulate glucose, galactose, and fructose uptake.
• Digestive processes convert complex carbohydrates into monosaccharides; absorption is tightly controlled by transporters (SGLT1, GLUT2, GLUT5) and is largely directed to the liver via the portal circulation.
• The liver serves as a central metabolic hub, deciding whether monosaccharides are used for energy, stored as glycogen, or converted to fat; excessive or rapid glucose delivery can contribute to de novo lipogenesis and insulin resistance in the long term.
• Dietary fiber provides substantial health benefits, including improved glycemic control, lipid-lowering effects, and favorable changes in gut microbiota; the combination of soluble and insoluble fibers yields the strongest metabolic benefits.
• Understanding the balance of carbohydrates, fiber, and nutrient timing is essential for managing energy balance, cardiovascular risk, diabetes risk, and overall metabolic health.